Home ProductsPharmaceutical Raw Materials

CAS 98319-26-7 Pharmaceutical Raw Materials Finasteride Hair Growth Steroids

Certification
Good quality Muscle Growth Hormone for sales
Your products is fantastic, I will buy more later

—— Michael

I'm Online Chat Now

CAS 98319-26-7 Pharmaceutical Raw Materials Finasteride Hair Growth Steroids

China CAS 98319-26-7 Pharmaceutical Raw Materials Finasteride Hair Growth Steroids supplier
CAS 98319-26-7 Pharmaceutical Raw Materials Finasteride Hair Growth Steroids supplier CAS 98319-26-7 Pharmaceutical Raw Materials Finasteride Hair Growth Steroids supplier CAS 98319-26-7 Pharmaceutical Raw Materials Finasteride Hair Growth Steroids supplier

Large Image :  CAS 98319-26-7 Pharmaceutical Raw Materials Finasteride Hair Growth Steroids

Product Details:

Place of Origin: Hubei, China
Brand Name: Mking
Certification: ISO9001, SGS
Model Number: CAS: 98319-26-7

Payment & Shipping Terms:

Minimum Order Quantity: 1g
Price: USD1/g
Packaging Details: As required
Delivery Time: In 24 hours
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 400kg/MONTH
Contact Now
Detailed Product Description
Keywords: Finasteride Alias: Estradiol
Policy: Reshipping Policy Purity: 99.6%
Shipping: TNT, EMS, HKEMS, FEDEX, DHL Shipping Time: 5-7 Working Days
Description: White Powder Standard: USP

CAS 98319-26-7 Pharmaceuticals Raw Materials Finasteride for Hair Growth

 

Finasteride (Steroids) Spec.
English Synonyms: PROSCAR;PROSTIDE;MK-906
CAS NO.: 98319-26-7
Assay: 99%
Molecular Formula:C23H36N2O2
Molecular Weight:372.54
Packing:foil bag or as require
Appearance: White or white crystalline solid. Soluble in chloroform, dimethyl sulfoxide, ethanol, methanol or propanol, insoluble in propylene glycol or polyethylene glycol 400
Usage: The drug can be very effective in reducing blood and dihydro testosterone within the prostate. Finasteride no affinity to the androgen receptor

 

Prostate enlargement


Physicians sometimes use finasteride for the treatment of BPH, informally known as an enlarged prostate. Finasteride may improve the symptoms associated with BPH such as difficulty urinating, getting up during the night to urinate, hesitation at the start of urination, and decreased urinary flow. It provides less symptomatic relief than alpha-1 blockers such as tamsulosin and symptomatic relief is slower in onset (six months or more of treatment with finasteride may be required to determine the therapeutic results of treatment). Symptomatic benefits are mainly seen in those with prostate volume > 40 cm3. In long-term studies finasteride but not alpha-1 inhibitors reduce the risk of acute urinary retention (−57% at 4 years) and the need for surgery (−54% at 4 years). If the drug is discontinued, any therapeutic benefits reverse within about 6-8 months.

 

COA

 

Test Items Specification Test Results
Description White or off-white crystalline powder Off-white crystalline powder
Specific rotation -56°~-60° -58.2°
Identification IR Matches with working standard Complies
  HPLC    
Solubility Freely soluble in chloroform and in alcohol Conform
  Very slightly soluble in water  
Heavy metals ≤10ppm <10ppm
Water ≤0.3% 0.22%
Residue on ignition ≤0.1% 0.05%
Relative material Maximum impurities≤0.5% 0.36%
  Total impurities≤1.0% 0.52%
Assay 98.5~101.0% 99.48%
Conclusion Passed

 

Finasteride works by blocking the conversion of the hormone testosterone to dihydrotestosterone in the prostate. It does this by blocking an enzyme called 5-alpha reductase. Dihydrotestosterone is partly responsible for making the prostate enlarge.

 

Therefore a reduced amount of dihydrotestosterone in the prostate causes it to shrink. This helps you to pass urine more easily.

 

Physicians use finasteride for the treatment of benign prostatic hyperplasia (BPH), informally known as an enlarged prostate. The FDA-approved dose is 5 mg once a day. Six months or more of treatment with finasteride may be required to determine the therapeutic results of treatment.

 

If the drug is discontinued, any therapeutic benefits reverse within about 6–8 months. Finasteride may improve the symptoms associated with BPH such as difficulty urinating, getting up during the night to urinate, hesitation at the start of urination, and decreased urinary flow.

 

CAS 98319-26-7 Pharmaceutical Raw Materials Finasteride Hair Growth Steroids

Contact Details
Hubei Mking Biotech Co., Ltd.

Contact Person: sales

Send your inquiry directly to us (0 / 3000)